Article originally published in RAJ Pharma in July 2008
By 2015 nanotechnology-based medicines and medical devices are expected to flood the global market. Brian Kelly and Peter Bogaert discuss the regulatory and legal implications of medical nanotechnology in Europe.
Nanotechnologies are the design, characterisation, production and application of structures, devices and systems by controlling shape and size